Searched for
ANJAN DRUG
ADIA, HarbourVest eye minor stake in CohanceADIA and HarbourVest are in discussions to acquire a minority stake in Cohance Lifesciences, a pharmaceuticals platform owned by Advent Int...- Lupin unit introduces inhaler for asthma patients in GermanyDrug firm Lupin on Friday said its unit has launched a pressurized metered dose inhaler for the treatment of asthma and chronic obstructive...
- Washing powder maker Nirma and Sekhmet vie for $731 million Glenmark Life stake: SourcesNirma, known for its eponymous washing detergent brand, have entered the final round of bidding for a stake of about 83% in the Mumbai-list...
- PAG-led Sekhmet Pharmaventures announces the hiring of Anil Khubchandani as MD and CEOKhubchandani, in his most recent role, has served as Co-CEO and Whole-time Director of Jubilant Ingrevia. Over his 20-year career at Jubila...
- PAG-led API Platform acquire controlling stake in OptimusFounded in 2004, Optimus is a vertically integrated manufacturer of pharmaceutical products, including advanced intermediates, active pharm...
- PAG, partners buy controlling stake in Optimus for Rs 2,000 crorePAG, a leading alternative investment firm focused on Asia-Pacific, along with consortium partners CX Partners and Samara Capital, on Wedne...
- PAG to acquire contact manufacturer Acme FormulationFounded in 2005 by Viral Shah, Acme provides contract development and manufacturing services to major Indian and global pharmaceutical comp...
- Solara promoter, TPG plan to sell stake in companyThe company has seen a near five-fold jump in its share price, giving promoters Kumar and his partner KR Ravishankar an additional reason t...
- PAG-led platform Gamot buys 70% in Chennai-based Anjan DrugPE major has joined hands with CX Partners, Samara Capital to invest up to $500 m in Indian pharma companies. Gamot will be led by PAG as a...
- CPI leader A B Bardhan's condition showing improvementThe condition of CPI leader A B Bardhan, who was admitted to a hospital here after he suffered a paralytic stroke, is "improving".
- Budget 2014: Healthcare sector welcomes move for more AIIMS in IndiaSuneeta Reddy said the proposals for 4 new AIIMS like institutions and thereafter in every state in the coming years augured well.
- Evolvence India Life Sciences Fund keen to exit Dr Agarwal’s HealthcareDr Agarwal’s has more than 70 hospitals across states such as TN, AP and Rajasthan and has plans to build new hospitals in other states.
- Biocon gets approval to market anti-psoriasis drug Itolizumab by DCGIThe company said the approval paved the way for the launch of the product, under the brand name Alzumab.
- How Gurgaon based startup Knimbus helps scientists share findings and connect with peersKnimbus has built a search and collaboration platform that aims to knock down the ivory towers confining global scientific research.
- Cipla shocks rivals by slashing cancer drug prices up to 75%Kidney cancer drug will now be available at Rs 6,840 for a month's supply, down from Rs 28,000. Lung cancer drug will cost Rs 4,250, down f...
- Emcure signs deal to manufacture Roche's anti-cancer drugsSwiss drug major Roche, which is often at logger heads with Indian generic drugmakers over patent rights, has made a shift in its strategy.
- Strides sells Australian unit to Watson Pharma for AUD 375 mnDrug firm Strides Arcolab today said it has sold its entire stake in Australian subsidiary Ascent Pharmahealth to Watson Pharmaceuticals fo...
- Novartis, GlaxoSmithKline, Pfizer & Ranbaxy focus on hinterlandBig drugmakers such as Novartis, GlaxoSmithKline, Pfizer, Ranbaxy and Aventis are keen to emulate the consumer industry's success in the hi...
- RIL gets highest number of trademarks in 2008Reliance Industries, India's most-valued firm, has got the maximum number of trademarks in the financial year 2007-08, while FMCG major HUL...
- Pfizer to set up 600 smoking cessation clinics in 2 yearsPfizer India plans to launch 600 smoking cessation clinics across the country in the next two years in partnership with private sector hosp...
Load More
